EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of English language proficiency and breast cancer oncologic outcomes

Revathi Ravella iD, Lillian A Boe, Anushri Mahabir, Boris A Mueller, Emma N Hahesy iD, Jeehee Isabelle Choi, Anyi Li, Simon N Powell, Atif J Khan, Lior Z Braunstein iD

JNCI Cancer Spectrum · 2026

DOI: 10.1093/jncics/pkag079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI Cancer Spectrum, 2026. Verfasst von Revathi Ravella und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, United States. Hauptthemen laut MEDLINE: Breast Neoplasms, Language, Limited English Proficiency. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Achar Meyohas Family, the Lois Green Fund, Rose-Margulies Family Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Few studies have compared oncologic outcomes directly between English-speaking (ES) and non-English-speaking (NES) patients. We performed a matched cohort study of stage I-III breast cancer patients with ES patients propensity matched 3:1 to NES patients based on age, tumor stage, nodal involvement, and receipt of adjuvant therapy. Patients were categorized as ES or NES according to preferred language documented in the electronic medical record. Primary outcomes were locoregional recurrence (LRR), disease-free survival (DFS), and overall survival (OS). Among 2768 patients (2076 ES; 692 NES), median age at diagnosis was 62 years (range = 25-94). Ten-year LRR was 9.5% vs 13% (P = .032), 10-year DFS was 71% vs 63% (P = .008), and 10-year OS was 79% vs 74% (P = .12) for ES and NES patients, respectively. These findings suggest that NES patients may have inferior breast cancer outcomes, even in highly resourced academic environments. These findings highlight the need for targeted interventions beyond language assistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsLanguageLimited English ProficiencyHumansFemaleNeoplasm Recurrence, LocalDisease-Free SurvivalAgedMiddle AgedAdultAged, 80 and overNeoplasm StagingCohort StudiesPropensity Score

Autor:innen und Institutionen

  • Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Department of Neuroscience, Princeton University, Princeton, NJ, United States.

ORCID-Profile: Revathi Ravella, Emma N Hahesy, Lior Z Braunstein

Förderung

  • NCI NIH HHS
  • Achar Meyohas Family, the Lois Green Fund
  • Rose-Margulies Family Research Fund

Zitieren

APA

Ravella, R., Boe, L. A., Mahabir, A., Mueller, B. A., Hahesy, E. N., Choi, J. I., Li, A., Powell, S. N., Khan, A. J., & Braunstein, L. Z. (2026). Association of English language proficiency and breast cancer oncologic outcomes. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkag079

Vancouver

Ravella R, Boe LA, Mahabir A, Mueller BA, Hahesy EN, Choi JI, et al. Association of English language proficiency and breast cancer oncologic outcomes. JNCI Cancer Spectrum. 2026. doi:10.1093/jncics/pkag079

BibTeX
@article{Ravella2026,
  author = {Ravella, Revathi and Boe, Lillian A and Mahabir, Anushri and Mueller, Boris A and Hahesy, Emma N and Choi, Jeehee Isabelle and Li, Anyi and Powell, Simon N and Khan, Atif J and Braunstein, Lior Z},
  title = {Association of English language proficiency and breast cancer oncologic outcomes},
  journal = {JNCI Cancer Spectrum},
  year = {2026},
  doi = {10.1093/jncics/pkag079}
}
Kostenlos starten →